PCR技術の市場規模および予測（2020年 - 2030年）、世界および地域シェア、動向、成長機会分析レポートカバレッジ：技術別（リアルタイムPCR、コンベンショナルPCR、逆転写PCR、デジタルPCR、マルチプレックスRT PCR、ホットスタートPCR、その他）、製品別（試薬・消耗品、装置、ソフトウェア・サービス）、用途別（遺伝子発現解析、遺伝子配列決定、遺伝子型判定、核酸合成、エンドユーザー（病院・診断センター、学術・研究機関、製薬・バイオテクノロジー企業、その他）、地域（北米、欧州、アジア太平洋、中南米、中東・アフリカ）。

PCR Technology Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Real-Time PCR, Conventional PCR, Reverse Transcription PCR, Digital PCR, Multiplex RT PCR, Hot Start PCR, and Others), Offerings (Reagents and Consumables, Instruments, and Software and Services), Application (Gene Expression Analysis, Genetic Sequencing, Genotyping, Nucleic Acid Synthesis, Standard Validation, Point of Care Diagnostics, Environmental Application, and Others), End User (Hospitals and Diagnostic Centers, Academia and Research Institutes, Pharmaceutical and Biotechnology Companies, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

PCR技術市場は2022年の131億100万米ドルから2030年には245億2400万米ドルに成長すると予測され、2022年から2030年までの年平均成長率は8.2%と予測されている。遺伝病や感染症の蔓延の増加、PCR技術への投資と資金... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2024年1月5日	US$5,190 シングルユーザライセンスライセンス・価格情報注文方法はこちら	262	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

PCR技術市場は2022年の131億100万米ドルから2030年には245億2400万米ドルに成長すると予測され、2022年から2030年までの年平均成長率は8.2%と予測されている。遺伝病や感染症の蔓延の増加、PCR技術への投資と資金の急増がPCR技術市場の成長を促進する。

PCRは、遺伝子変異、感染症、バイオマーカーの迅速かつ正確な検出を可能にするため、臨床現場において極めて重要である。ポリメラーゼ連鎖反応(PCR)と呼ばれる一般的な分子生物学技術はDNAやRNA配列を増幅し、研究、診断、その他の分野で様々な応用を可能にする。さらに、慢性疾患の有病率の増加やゲノム研究の発展により、PCRベースの診断の必要性が高まっている。さらに、PCR装置、化学薬品、ソフトウェアの自動化、統合化、継続的な改良により、ワークフローの性能、感度、効率が向上し、市場拡大の原動力となっている。

遺伝病と感染症の有病率の上昇がPCR技術市場を牽引

国家機関の遺伝性疾患や先天性障害に関する情報によると、遺伝性疾患はまれな疾患であるが、合わせて毎年15,500件以上の陽性診断がある。MJH Life Sciences社（米国）が2022年に発表した報告書によると、世界では毎年30万人の新生児が鎌状赤血球症（SCD）で生まれ、世界人口の約5％を占めている。米国では、SCDは最も一般的な遺伝性疾患の一つである。米国疾病予防管理センター（CDC）によると、アフリカ系アメリカ人の500人に1人がSCDに罹患しており、そのうち約12人に1人が常染色体劣性突然変異に苦しんでいる。ノバルティス社（スイス）の2020年6月の報告によると、毎年約15,000人と270人の新生児がSCDと診断されている。この病気はインドのような新興国で最も多く見られます。インドの部族社会では、約1800万人が鎌状赤血球症（SCT）を発症しており、140万人がSCDに苦しんでいます。SCDの罹患率の上昇の結果、病理センターではデジタルポリメラーゼ連鎖反応（dPCR）の採用が増加しており、診断の確認や様々な臨床検査の設計のために様々なDNA特異的配列を標的とするこの技術が利用されている。このツールにより、研究者はリアルタイムPCRでは同定が困難な稀な遺伝子変異を検出することができる。

COVID-19の発生はPCR技術市場に大きな影響を与えた。PCRは、ほとんどの分子生物学研究所で、遺伝子型判定、クローニング、一塩基変異の解析のためにDNAの特定の伸長を増幅するために使われる、ほぼどこにでもある、堅牢で信頼性の高い技術である。増幅されたDNAは、ほとんどの次世代シーケンシング（NGS）準備の基礎となる。ほぼすべての診断検査では、COVID-19の症状を持つ人の検査にリアルタイムPCRが用いられている。バイオテクノロジーや製薬企業の大半は、COVID-19の新規化合物や治療アプローチを見つけるために研究開発部門に重点を移し、それがPCR技術市場に利益をもたらした。2022年2月、ロシュはCE認証を受け入れる国で使用されるCOVID-19 PCRのポートフォリオに、新たにリリースされた分子検査機器であるコバス5800システムを追加した。これらの製品には、コバスSARS-CoV-2およびインフルエンザA/B検査、コバスSARS-CoV-2定性検査が含まれる。この製品は、低、中、高容量の分子検査において均一な性能と効率を提供する。

市場機会

新興国におけるPCR技術の採用増加

近年、PCRのような分子手法は診断ツールとして発展し、医療従事者が様々な感染症を正確に診断できるようになった。また、不可欠な研究・診断ツールとも考えられている。PCRは疾病の早期診断を可能にし、それゆえ疾病対策に不可欠な役割を果たしている。この技術は、異なる検査室でも遜色のない再現性のある結果を提供し、世界中で受け入れられている。PCR技術は新興国でも広く受け入れられ、利用されている。世界保健機関（WHO）の「発展途上国におけるPCR検査施設の設立に関する報告書2016」によると、WHOはWHO東南アジア11カ国全てにPCR検査施設を設立するための技術支援を行っている。必要性に応じて、これらの施設は逆転写酵素PCR（RT-PCR）、マルチプレックスPCR、リアルタイムPCR、in-situ PCR、dPCRなどの異なるPCR技術を採用している。PCR技術の応用は、臨床微生物学、ウイルス学、寄生虫学、バイオテクノロジー、および関連分野で増加している。したがって、発展途上国のPCR技術市場は予測期間中に有利な機会を経験すると予想される。

世界のPCR技術市場」は、技術、製品、用途、エンドユーザー、地域によって区分される。

技術ベースの洞察

PCR技術市場は技術に基づき、リアルタイムPCR、コンベンショナルPCR、逆転写、デジタルPCR（dPCR）、マルチプレックスRT-PCR、ホットスタートPCR、その他に区分される。リアルタイムPCRセグメントは2022年に大きな市場シェアを占め、同セグメントは2022-2030年に8.8%の高いCAGRを記録すると予測されている。リアルタイムPCRは、ウイルスを含むあらゆる疾患の特定の遺伝物質を同定するための核ベースのアプローチである。リアルタイムPCRは、遺伝子を定量化する最も広く使われている方法の1つとなっている。そのダイナミックレンジ、顕著な感度、非常に配列特異的であること、増幅後の処理が不要であること、サンプルのスループットを向上させる能力などの利点から、これらの利点を最大限に活用するには、アクセス可能な多くの実行オプションを十分に認識する必要がある。

製品に基づく洞察

PCRテクノロジー市場は、試薬と消耗品、機器、ソフトウェアとサービスに区分される。試薬・消耗品セグメントは2022年に大きな市場シェアを占めた。さらに、同セグメントは2022-2030年に9.1%という高いCAGRを記録すると予測されている。試薬と消耗品はPCRの手順に不可欠な部品である。これにはバッファー、プローブ、酵素、色素、バイアル、キット、パネルが含まれる。また、遺伝子発現解析、SNPジェノタイピング解析、マイクロRNA解析などのためのキットもある。病気の早期発見に対する需要の高まり、消耗品や試薬の普及、ヘルスケアや研究、その他の目的でのPCRの需要拡大が、このセグメントの市場を大きく促進している。Thermo Fisher Scientific、Kaneka Eurogentec S.A.、QIAGENといったメーカーの存在が、試薬・消耗品セグメントを特徴づけている。さらに、頻繁な製品の発売、技術革新の受け入れの増加、製品の入手可能性の増加も、このセグメントの市場成長に寄与する主な要因の一つである。

アプリケーションベースの洞察

アプリケーションに基づき、PCR技術市場は遺伝子発現解析、遺伝子配列決定、ジェノタイピング、核酸合成、標準バリデーション、ポイントオブケア診断アプリケーション、環境アプリケーション、その他に区分される。遺伝子発現解析セグメントは2022年に大きな市場シェアを占めた。さらに、同分野は2022～2030年のCAGRが9.0％と高くなると予測されている。遺伝子発現解析は、機能的RNA種またはタンパク質産物に向けて機能的遺伝子産物を合成するために遺伝子がどのように記録されるかを調べる。遺伝子制御の研究は、分化のような正常な細胞プロセスや、異常または病理学的プロセスに対するビジョンを提供するのに役立つ。研究者は、遺伝子発現が制御される様々なレベル、すなわち転写、転写後、翻訳、翻訳後タンパク質修飾のいずれかで遺伝子発現解析を行うことができる。

エンドユーザーベースの洞察

エンドユーザーに基づき、PCR技術市場は病院・診断センター、製薬・バイオテクノロジー企業、研究所・学術機関、その他に区分される。2022年の市場シェアは、病院・診断センター分野が大きい。さらに、同セグメントは2022-2030年に8.7%という高いCAGRを記録すると予測されている。病院と診断センターはPCR技術市場で大きな市場シェアを占めている。病院は、高度に訓練されたスタッフの指導の下、高度に先進的な治療を求める患者のための主要なセンターである。dPCRやqPCRのような様々なPCR技術は高い感度と特異性を提供し、細菌、ウイルス、真菌を含む病原体の早期かつ正確な検出を可能にする。病院はまた、急性および慢性疾患を治療するために、患者に高度な診断と治療の選択肢を提供しており、病院や診断センターは医療施設に専門的な科学機器を提供しているため、PCR技術の採用率ははるかに高くなっています。診断検査室は、検査する様々なサンプルの容易なワークフローと管理を可能にするハイテク機器を備えている。例えば、Bio-Rad Laboratories, Inc.、Fluidigm Corporation、Eppendorf、Agilent Technologies, Inc.は、病院や診断センターに、その能力と要求に応じてPCR装置を提供している。

食品医薬品局、製薬協、日本バイオインダストリー協会などはPCR技術市場調査報告書を作成する際に参照した関連情報源である。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 PCR Technologies Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. PCR Technologies Market Landscape
4.1 Overview
4.2 Global PEST Analysis
5. PCR Technologies Market – Key Industry Dynamics
5.1 PCR Technologies Market – Key Industry Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Genetic and Infectious Diseases
5.2.2 Surging Investments and Funds Availability for PCR Technologies
5.3 Market Restraints
5.3.1 High Costs of PCR Systems and Availability of Alternative Assays
5.4 Market Opportunities
5.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
5.5 Future Trends
5.5.1 Advancements in PCR Technologies
5.6 Impact of Drivers and Restraints:
6. PCR Technologies Market – Global Market Analysis
6.1 PCR Technologies Market Revenue (US$ Million), 2022 – 2030
7. PCR Technologies Market Analysis – By Technology
7.1 Overview
7.2 Real Time PCR
7.2.1 Overview
7.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Conventional PCR
7.3.1 Overview
7.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Reverse Transcription PCR
7.4.1 Overview
7.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
7.5 Digital PCR
7.5.1 Overview
7.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
7.6 Multiplex RT PCR
7.6.1 Overview
7.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
7.7 Hot Start PCR
7.7.1 Overview
7.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
8. PCR Technologies Market Analysis – By Offerings
8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
8.3 Reagents and Consumables
8.3.1 Overview
8.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Reagents and Consumables
8.3.2.1.1 PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Vial Size
8.4 Instruments
8.4.1 Overview
8.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Instruments
8.5 Software and Services
8.5.1 Overview
8.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)
9. PCR Technologies Market Analysis – By Application
9.1 Overview
9.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Gene Expression Analysis
9.3.1 Overview
9.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Genetic Sequencing
9.4.1 Overview
9.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Genotyping
9.5.1 Overview
9.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Nucleic Acid Synthesis
9.6.1 Overview
9.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
9.7 Standard Validation
9.7.1 Overview
9.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
9.8 Point of Care Diagnostics
9.8.1 Overview
9.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
9.9 Environmental Application
9.9.1 Overview
9.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
9.10 Others
9.10.1 Overview
9.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. PCR Technologies Market Analysis – By End User
10.1 Overview
10.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Diagnostic Centers
10.3.1 Overview
10.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
10.4 Academia and Research Institutes
10.4.1 Overview
10.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
10.5 Pharmaceutical and Biotechnology Companies
10.5.1 Overview
10.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
11. PCR Technologies Market – Geographical Analysis
11.1 North America: PCR Technologies Market
11.1.1 Overview
11.1.2 North America PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.1 North America PCR Technologies Market Revenue and Forecast and Analysis – By Technology
11.1.2.2 North America PCR Technologies Market Revenue and Forecast and Analysis – By Offerings
11.1.2.2.1 North America PCR Technologies Market Revenue and Forecast and Analysis – By Instruments
11.1.2.2.2 North America PCR Technologies Market Revenue and Forecast and Analysis – By Reagents And Consumables
11.1.2.2.2.1 North America PCR Technologies Market Revenue and Forecast and Analysis – By Vial Size
11.1.2.3 North America PCR Technologies Market Revenue and Forecast and Analysis – By Application
11.1.2.4 North America PCR Technologies Market Revenue and Forecast and Analysis – By End User
11.1.3 North America PCR Technologies Market Revenue and Forecast and Analysis – By Country
11.1.3.1 United States: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.1.1 Overview
11.1.3.2 United States PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3.2.1 United States PCR Technologies Market Breakdown by Technology
11.1.3.2.2 United States PCR Technologies Market Breakdown by Offerings
11.1.3.2.2.1 United States PCR Technologies Market Breakdown by Instruments
11.1.3.2.2.2 United States PCR Technologies Market Breakdown by Reagents And Consumables
11.1.3.2.2.2.1 United States PCR Technologies Market Breakdown by Vial Size
11.1.3.2.3 United States PCR Technologies Market Breakdown by Application
11.1.3.2.4 United States PCR Technologies Market Breakdown by End User
11.1.3.3 Canada: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.3.1 Overview
11.1.3.4 Canada PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3.4.1 Canada PCR Technologies Market Breakdown by Technology
11.1.3.4.2 Canada PCR Technologies Market Breakdown by Offerings
11.1.3.4.2.1 Canada PCR Technologies Market Breakdown by Instruments
11.1.3.4.2.2 Canada PCR Technologies Market Breakdown by Reagents And Consumables
11.1.3.4.2.2.1 Canada PCR Technologies Market Breakdown by Vial Size
11.1.3.4.3 Canada PCR Technologies Market Breakdown by Application
11.1.3.4.4 Canada PCR Technologies Market Breakdown by End User
11.1.3.5 Mexico: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.5.1 Overview
11.1.3.6 Mexico PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3.6.1 Mexico PCR Technologies Market Breakdown by Technology
11.1.3.6.2 Mexico PCR Technologies Market Breakdown by Offerings
11.1.3.6.2.1 Mexico PCR Technologies Market Breakdown by Instruments
11.1.3.6.2.2 Mexico PCR Technologies Market Breakdown by Reagents And Consumables
11.1.3.6.2.2.1 Mexico PCR Technologies Market Breakdown by Vial Size
11.1.3.6.3 Mexico PCR Technologies Market Breakdown by Application
11.1.3.6.4 Mexico PCR Technologies Market Breakdown by End User
11.2 Europe: PCR Technologies Market
11.2.1 Overview
11.2.2 Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.1 Europe PCR Technologies Market Revenue and Forecast and Analysis – By Technology
11.2.2.2 Europe PCR Technologies Market Revenue and Forecast and Analysis – By Offerings
11.2.2.2.1 Europe PCR Technologies Market Revenue and Forecast and Analysis – By Instruments
11.2.2.2.2 Europe PCR Technologies Market Revenue and Forecast and Analysis – By Reagents And Consumables
11.2.2.2.2.1 Europe PCR Technologies Market Revenue and Forecast and Analysis – By Vial Size
11.2.2.3 Europe PCR Technologies Market Revenue and Forecast and Analysis – By Application
11.2.3 Europe PCR Technologies Market Breakdown by End User
11.2.3.1 Europe PCR Technologies Market Revenue and Forecast and Analysis – By End User
11.2.4 Europe PCR Technologies Market Revenue and Forecast and Analysis – By Country
11.2.4.1 Germany: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.2.4.1.1 Overview
11.2.4.2 Germany PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.2.4.2.1 Germany PCR Technologies Market Breakdown by Technology
11.2.4.2.2 Germany PCR Technologies Market Breakdown by Offerings
11.2.4.2.2.1 Germany PCR Technologies Market Breakdown by Instruments
11.2.4.2.2.2 Germany PCR Technologies Market Breakdown by Reagents And Consumables
11.2.4.2.2.2.1 Germany PCR Technologies Market Breakdown by Vial Size
11.2.4.2.3 Germany PCR Technologies Market Breakdown by Application
11.2.4.2.4 Germany PCR Technologies Market Breakdown by End User
11.2.4.3 United Kingdom: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.2.4.3.1 Overview
11.2.4.4 United Kingdom PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.2.4.4.1 United Kingdom PCR Technologies Market Breakdown by Technology
11.2.4.4.2 United Kingdom PCR Technologies Market Breakdown by Offerings
11.2.4.4.2.1 United Kingdom PCR Technologies Market Breakdown by Instruments
11.2.4.4.2.2 United Kingdom PCR Technologies Market Breakdown by Reagents And Consumables
11.2.4.4.2.2.1 United Kingdom PCR Technologies Market Breakdown by Vial Size
11.2.4.4.3 United Kingdom PCR Technologies Market Breakdown by Application
11.2.4.4.4 United Kingdom PCR Technologies Market Breakdown by End User
11.2.4.5 France: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.2.4.5.1 Overview
11.2.4.6 France PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.2.4.6.1 France PCR Technologies Market Breakdown by Offerings
11.2.4.6.1.1 France PCR Technologies Market Breakdown by Instruments
11.2.4.6.1.2 France PCR Technologies Market Breakdown by Reagents And Consumables
11.2.4.6.1.2.1 France PCR Technologies Market Breakdown by Vial Size
11.2.4.6.2 France PCR Technologies Market Breakdown by Application
11.2.4.6.3 France PCR Technologies Market Breakdown by End User
11.2.4.7 Italy: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.2.4.7.1 Overview
11.2.4.8 Italy PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.2.4.8.1 Italy PCR Technologies Market Breakdown by Technology
11.2.4.8.2 Italy PCR Technologies Market Breakdown by Offerings
11.2.4.8.2.1 Italy PCR Technologies Market Breakdown by Instruments
11.2.4.8.2.2 Italy PCR Technologies Market Breakdown by Reagents And Consumables
11.2.4.8.2.2.1 Italy PCR Technologies Market Breakdown by Vial Size
11.2.4.8.3 Italy PCR Technologies Market Breakdown by Application
11.2.4.8.4 Italy PCR Technologies Market Breakdown by End User
11.2.4.9 Spain: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.2.4.9.1 Overview
11.2.4.10 Spain PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.2.4.10.1 Spain PCR Technologies Market Breakdown by Technology
11.2.4.10.2 Spain PCR Technologies Market Breakdown by Offerings
11.2.4.10.2.1 Spain PCR Technologies Market Breakdown by Instruments
11.2.4.10.2.2 Spain PCR Technologies Market Breakdown by Reagents And Consumables
11.2.4.10.2.2.1 Spain PCR Technologies Market Breakdown by Vial Size
11.2.4.10.3 Spain PCR Technologies Market Breakdown by Application
11.2.4.10.4 Spain PCR Technologies Market Breakdown by End User
11.2.4.11 Rest of Europe: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.2.4.11.1 Overview
11.2.4.12 Rest of Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.2.4.12.1 Rest of Europe PCR Technologies Market Breakdown by Technology
11.2.4.12.2 Rest of Europe PCR Technologies Market Breakdown by Offerings
11.2.4.12.2.1 Rest of Europe PCR Technologies Market Breakdown by Instruments
11.2.4.12.2.2 Rest of Europe PCR Technologies Market Breakdown by Reagents And Consumables
11.2.4.12.2.2.1 Rest of Europe PCR Technologies Market Breakdown by Vial Size
11.2.4.12.3 Rest of Europe PCR Technologies Market Breakdown by Application
11.2.4.12.4 Rest of Europe PCR Technologies Market Breakdown by End User
11.3 Asia Pacific: PCR Technologies Market
11.3.1 Overview
11.3.2 Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.1 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis – By Technology
11.3.2.2 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis – By Offerings
11.3.2.2.1 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis – By Instruments
11.3.2.2.2 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis – By Reagents And Consumables
11.3.2.2.3 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis – By Vial Size
11.3.2.3 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis – By Application
11.3.2.4 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis – By End User
11.3.3 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis – By Country
11.3.3.1 China: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.1.1 Overview
11.3.3.2 China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3.2.1 China PCR Technologies Market Breakdown by Technology
11.3.3.2.2 China PCR Technologies Market Breakdown by Offerings
11.3.3.2.2.1 China PCR Technologies Market Breakdown by Instruments
11.3.3.2.2.2 China PCR Technologies Market Breakdown by Reagents And Consumables
11.3.3.2.2.2.1 China PCR Technologies Market Breakdown by Vial Size
11.3.3.2.3 China PCR Technologies Market Breakdown by Application
11.3.3.2.4 China PCR Technologies Market Breakdown by End User
11.3.3.3 Japan PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.3.1 Overview
11.3.3.4 Japan PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3.4.1 Japan PCR Technologies Market Breakdown by Technology
11.3.3.4.2 Japan PCR Technologies Market Breakdown by Offerings
11.3.3.4.2.1 Japan PCR Technologies Market Breakdown by Instruments
11.3.3.4.2.2 Japan PCR Technologies Market Breakdown by Reagents And Consumables
11.3.3.4.2.2.1 Japan PCR Technologies Market Breakdown by Vial Size
11.3.3.4.3 Japan PCR Technologies Market Breakdown by Application
11.3.3.4.4 Japan PCR Technologies Market Breakdown by End User
11.3.3.5 India: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.5.1 Overview
11.3.3.6 India PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3.6.1 India PCR Technologies Market Breakdown by Technology
11.3.3.6.2 India PCR Technologies Market Breakdown by Offerings
11.3.3.6.2.1 India PCR Technologies Market Breakdown by Instruments
11.3.3.6.2.2 India PCR Technologies Market Breakdown by Reagents And Consumables
11.3.3.6.2.2.1 India PCR Technologies Market Breakdown by Vial Size
11.3.3.6.3 India PCR Technologies Market Breakdown by Application
11.3.3.6.4 India PCR Technologies Market Breakdown by End User
11.3.3.7 Australia: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.7.1 Overview
11.3.3.8 Australia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3.8.1 Australia PCR Technologies Market Breakdown by Technology
11.3.3.8.2 Australia PCR Technologies Market Breakdown by Offerings
11.3.3.8.2.1 Australia PCR Technologies Market Breakdown by Instruments
11.3.3.8.2.2 Australia PCR Technologies Market Breakdown by Reagents And Consumables
11.3.3.8.2.2.1 Australia PCR Technologies Market Breakdown by Vial Size
11.3.3.8.3 Australia PCR Technologies Market Breakdown by Application
11.3.3.8.4 Australia PCR Technologies Market Breakdown by End User
11.3.3.9 South Korea: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.9.1 Overview
11.3.3.10 South Korea PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3.10.1 South Korea PCR Technologies Market Breakdown by Technology
11.3.3.10.2 South Korea PCR Technologies Market Breakdown by Offerings
11.3.3.10.2.1 South Korea PCR Technologies Market Breakdown by Instruments
11.3.3.10.2.2 South Korea PCR Technologies Market Breakdown by Reagents And Consumables
11.3.3.10.2.2.1 South Korea PCR Technologies Market Breakdown by Vial Size
11.3.3.10.3 South Korea PCR Technologies Market Breakdown by Application
11.3.3.10.4 South Korea PCR Technologies Market Breakdown by End User
11.3.3.11 Rest of APAC: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.11.1 Overview
11.3.3.12 Rest of APAC PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3.12.1 Rest of APAC PCR Technologies Market Breakdown by Technology
11.3.3.12.2 Rest of APAC PCR Technologies Market Breakdown by Offerings
11.3.3.12.2.1 Rest of APAC PCR Technologies Market Breakdown by Instruments
11.3.3.12.2.2 Rest of APAC PCR Technologies Market Breakdown by Reagents And Consumables
11.3.3.12.2.2.1 Rest of APAC PCR Technologies Market Breakdown by Vial Size
11.3.3.12.3 Rest of APAC PCR Technologies Market Breakdown by Application
11.3.3.12.4 Rest of APAC PCR Technologies Market Breakdown by End User
11.4 Middle East and Africa: PCR Technologies Market
11.4.1 Overview
11.4.2 Middle East and Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.4.2.1 Middle East and Africa PCR Technologies Market Revenue and Forecast and Analysis – By Technology
11.4.2.2 Middle East and Africa PCR Technologies Market Revenue and Forecast and Analysis – By Offerings
11.4.2.2.1 Middle East and Africa PCR Technologies Market Revenue and Forecast and Analysis – By Instruments
11.4.2.2.2 Middle East and Africa PCR Technologies Market Revenue and Forecast and Analysis – By Reagents And Consumables
11.4.2.2.2.1 Middle East and Africa PCR Technologies Market Revenue and Forecast and Analysis – By Vial Size
11.4.2.3 Middle East and Africa PCR Technologies Market Revenue and Forecast and Analysis – By Application
11.4.2.4 Middle East and Africa PCR Technologies Market Revenue and Forecast and Analysis – By End User
11.4.3 Middle East and Africa PCR Technologies Market Revenue and Forecast and Analysis – By Country
11.4.3.1 Saudi Arabia: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.1.1 Overview
11.4.3.2 Saudi Arabia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3.2.1 Saudi Arabia PCR Technologies Market Breakdown by Technology
11.4.3.2.2 Saudi Arabia PCR Technologies Market Breakdown by Offerings
11.4.3.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Instruments
11.4.3.2.2.2 Saudi Arabia PCR Technologies Market Breakdown by Reagents And Consumables
11.4.3.2.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Vial Size
11.4.3.2.3 Saudi Arabia PCR Technologies Market Breakdown by Application
11.4.3.2.4 Saudi Arabia PCR Technologies Market Breakdown by End User
11.4.3.3 South Africa: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.3.1 Overview
11.4.3.4 South Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3.4.1 South Africa PCR Technologies Market Breakdown by Technology
11.4.3.4.2 South Africa PCR Technologies Market Breakdown by Offerings
11.4.3.4.2.1 South Africa PCR Technologies Market Breakdown by Instruments
11.4.3.4.2.2 South Africa PCR Technologies Market Breakdown by Reagents And Consumables
11.4.3.4.2.2.1 South Africa PCR Technologies Market Breakdown by Vial Size
11.4.3.4.3 South Africa PCR Technologies Market Breakdown by Application
11.4.3.4.4 South Africa PCR Technologies Market Breakdown by End User
11.4.3.5 United Arab Emirates: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.5.1 Overview
11.4.3.6 United Arab Emirates PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3.6.1 United Arab Emirates PCR Technologies Market Breakdown by Technology
11.4.3.6.2 United Arab Emirates PCR Technologies Market Breakdown by Offerings
11.4.3.6.2.1 United Arab Emirates PCR Technologies Market Breakdown by Instruments
11.4.3.6.2.2 United Arab Emirates PCR Technologies Market Breakdown by Reagents And Consumables
11.4.3.6.2.2.1 United Arab Emirates PCR Technologies Market Breakdown by Vial Size
11.4.3.6.3 United Arab Emirates PCR Technologies Market Breakdown by Application
11.4.3.6.4 United Arab Emirates PCR Technologies Market Breakdown by End User
11.4.3.7 Rest of Middle East and Africa: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.7.1 Overview
11.4.3.8 Rest of Middle East and Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3.8.1 Rest of Middle East and Africa PCR Technologies Market Breakdown by Technology
11.4.3.8.2 Rest of Middle East and Africa PCR Technologies Market Breakdown by Offerings
11.4.3.8.2.1 Rest of Middle East and Africa PCR Technologies Market Breakdown by Instruments
11.4.3.8.2.2 Rest of Middle East and Africa PCR Technologies Market Breakdown by Reagents And Consumables
11.4.3.8.2.2.1 Rest of Middle East and Africa PCR Technologies Market Breakdown by Vial Size
11.4.3.8.3 Rest of Middle East and Africa PCR Technologies Market Breakdown by Application
11.4.3.8.4 Rest of Middle East and Africa PCR Technologies Market Breakdown by End User
11.5 South and Central America: PCR Technologies Market
11.5.1 Overview
11.5.2 South and Central America PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.5.2.1 South and Central America PCR Technologies Market Revenue and Forecast and Analysis – By Technology
11.5.2.2 South and Central America PCR Technologies Market Revenue and Forecast and Analysis – By Offerings
11.5.2.2.1 South and Central America PCR Technologies Market Revenue and Forecast and Analysis – By Instruments
11.5.2.2.2 South and Central America PCR Technologies Market Revenue and Forecast and Analysis – By Reagents And Consumables
11.5.2.2.2.1 South and Central America PCR Technologies Market Revenue and Forecast and Analysis – By Vial Size
11.5.2.3 South and Central America PCR Technologies Market Revenue and Forecast and Analysis – By Application
11.5.2.4 South and Central America PCR Technologies Market Revenue and Forecast and Analysis – By End User
11.5.3 South and Central America PCR Technologies Market Revenue and Forecast and Analysis – By Country
11.5.3.1 Brazil: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.1.1 Overview
11.5.3.2 Brazil PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3.2.1 Brazil PCR Technologies Market Breakdown by Technology
11.5.3.2.2 Brazil PCR Technologies Market Breakdown by Offerings
11.5.3.2.2.1 Brazil PCR Technologies Market Breakdown by Instruments
11.5.3.2.2.2 Brazil PCR Technologies Market Breakdown by Reagents And Consumables
11.5.3.2.2.2.1 Brazil PCR Technologies Market Breakdown by Vial Size
11.5.3.2.3 Brazil PCR Technologies Market Breakdown by Application
11.5.3.2.4 Brazil PCR Technologies Market Breakdown by End User
11.5.3.3 Argentina: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.3.1 Overview
11.5.3.4 Argentina PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3.4.1 Argentina PCR Technologies Market Breakdown by Technology
11.5.3.4.2 Argentina PCR Technologies Market Breakdown by Offerings
11.5.3.4.2.1 Argentina PCR Technologies Market Breakdown by Instruments
11.5.3.4.2.2 Argentina PCR Technologies Market Breakdown by Reagents And Consumables
11.5.3.4.2.2.1 Argentina PCR Technologies Market Breakdown by Vial Size
11.5.3.4.3 Argentina PCR Technologies Market Breakdown by Application
11.5.3.4.4 Argentina PCR Technologies Market Breakdown by End User
11.5.3.5 Rest of South and Central America: PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.5.1 Overview
11.5.3.6 Rest of South and Central America PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3.6.1 Rest of South and Central America PCR Technologies Market Breakdown by Technology
11.5.3.6.2 Rest of South and Central America PCR Technologies Market Breakdown by Offerings
11.5.3.6.2.1 Rest of South and Central America PCR Technologies Market Breakdown by Instruments
11.5.3.6.2.2 Rest of South and Central America PCR Technologies Market Breakdown by Reagents And Consumables
11.5.3.6.2.2.1 Rest of South and Central America PCR Technologies Market Breakdown by Vial Size
11.5.3.6.3 Rest of South and Central America PCR Technologies Market Breakdown by Application
11.5.3.6.4 Rest of South and Central America PCR Technologies Market Breakdown by End User
12. PCR Technologies Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in the PCR Technologies Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Promega Corp
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN NV
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 bioMerieux SA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Hoffmann-La Roche Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bio-Rad Laboratories Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Becton Dickinson and Co
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Atila Biosystems Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Takara Bio Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Standard BioTools Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Agilent Technologies Inc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Visby Medical Inc
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Ellume Ltd
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
14. Appendix
14.1 About The Insight Partners

ページTOPに戻る

Table of Contents

Summary

The PCR technologies market is expected to grow from US$ 13.101 billion in 2022 to US$ 24.524 billion by 2030; it is anticipated to register a CAGR of 8.2% from 2022 to 2030. The rising prevalence of genetic and infectious diseases and surging investments and funds for PCR technologies propel the PCR technologies market growth.

PCR is crucial in clinical settings as it enables rapid and precise detection of genetic variants, infectious diseases, and biomarkers. A popular molecular biology technique called polymerase chain reaction (PCR) amplifies DNA and RNA sequences, enabling various applications in research, diagnostics, and other areas. In addition, the need for PCR-based diagnostics has been fueled due to the increasing prevalence of chronic diseases and developments in genomic research. Additionally, automation, integration, and ongoing improvements in PCR instruments, chemicals, and software have increased the performance, sensitivity, and efficiency of workflows, thereby driving the expansion of the market.

Rising Prevalence of Genetic and Infectious Diseases Drives the PCR Technologies Market

According to the National Organization's information on genetic conditions or congenital disabilities, genetic disorders are rare conditions, but they collectively comprise over 15,500 positive diagnoses every year. Estimates published in a report by MJH Life Sciences (US) in 2022 state that ~300,000 newborns are born with sickle cell disease (SCD) globally every year, accounting for ∼5% of the global population. In the US, SCD is one of the most prevalent genetic conditions. According to the Centers for Disease Control and Prevention (CDC), 1 in 500 African Americans is affected by an SCD, and ∼1 in 12 of them suffer from the autosomal recessive mutation. As per the June 2020 report by Novartis AG (Switzerland), ∼15,000 individuals and 270 newborns are diagnosed with SCDs every year. The disease is most prevalent in emerging nations such as India. Among India's tribal communities, ∼18 million people exhibit sickle cell traits (SCTs), and 1.4 million people are suffering from SCDs. As a result of the rising incidence of SCDs, the adoption of digital polymerase chain reaction (dPCR) is increasing in pathology centers, wherein this technology is being exploited for targeting various DNA-specific sequences to confirm diagnoses and design various clinical tests. dPCR can target specific DNA sequences in just one molecule of DNA. This tool allows researchers to detect rare genetic mutations that are difficult to identify using real-time PCR.

The COVID-19 outbreak had a substantial effect on the PCR technologies market. PCR is a nearly ubiquitous, robust, and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and analysis of single nucleotide variations. The amplified DNA is the basis for most next-generation sequencing (NGS) preparations. Nearly all diagnostic tests used real-time PCR for testing people having symptoms of COVID-19. The majority of biotech and pharmaceutical businesses shifted their focus toward research and development divisions to find novel compounds or therapeutic approaches for COVID-19, which, in turn, benefitted the PCR technologies market. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These products include the Cobas SARS-CoV-2 and influenza A/B tests and the Cobas SARS-CoV-2 qualitative test. The product offers uniform performance and efficiency in low-, medium-, and high-volume molecular laboratory tests.

Market Opportunity

Increasing Adoption of PCR Techniques in Emerging Countries

In recent years, molecular methods such as PCR have evolved as diagnostic tools, enabling healthcare professionals to diagnose various infectious diseases accurately. It is also considered an indispensable research and diagnostic tool. PCR allows the early diagnosis of disease and hence plays an essential role in disease control. The technique provides reproducible results comparable to different laboratories and is accepted worldwide. PCR techniques are also being widely accepted and utilized in emerging countries. According to the World Health Organization Report on Establishment of PCR Laboratory in Developing Countries 2016, WHO provides technical assistance to establish PCR laboratories in all 11 WHO Southeast Asia countries. Depending on their need, these facilities have adopted different PCR technologies such as reverse transcriptase PCR (RT-PCR), multiplex PCR, real-time PCR, in-situ PCR, and dPCR. The application of PCR technologies is increasing in clinical microbiology, virology, parasitology, biotechnology, and allied fields due to this tool's simple, rapid, and highly specific screening. Thus, the PCR technologies market in developing countries is expected to experience lucrative opportunities during the forecast period.

The “Global PCR Technologies Market” is segmented based on technology, offerings, applications, end users, and geography.

Technology-Based Insights

The PCR technologies market is segmented based on technology into real-time PCR, conventional PCR, reverse transcription, digital PCR (dPCR), multiplex RT-PCR, hot start PCR, and others. The real-time PCR segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 8.8% during 2022–2030. Real-time PCR is a nuclear-based approach for identifying specific genetic material in any disease, including viruses. Real-time PCR has become one of the most extensively used methods of gene quantification. Because of its dynamic range, remarkable sensitivity, ability to be very sequence-specific, no post-amplification processing, and ability to increase sample throughput, getting the most out of these benefits necessitates a thorough awareness of the many running options accessible.

Offerings-Based Insights

Based on offerings, the PCR technologies market is segmented into reagents and consumables, instruments, and software and services. The reagents and consumables segment held a larger market share in 2022. Moreover, the same segment is anticipated to register a higher CAGR of 9.1% during 2022-2030. Reagents and consumables are essential parts of the PCR procedures. It includes buffers, probes, enzymes, dyes, vials, kits, and panels. Also, several kits are available for gene expression analysis, SNP genotyping analysis, microRNA analysis, and others. The growing demand for earlier detection of disease, widespread use of consumables and reagents, and expanding demand for PCRs for healthcare, research, and other purposes have significantly fueled the market for the segment. The presence of manufacturers, such as Thermo Fisher Scientific, Kaneka Eurogentec S.A., and QIAGEN, characterizes the reagents and consumables segment. Further, frequent product launches, rising acceptance of technology innovations, and increasing availability of the products are also among the major factors contributing to the market growth for the segment.

Application-Based Insights

Based on application, the PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held a larger market share in 2022. Moreover, the same segment is anticipated to register a higher CAGR of 9.0% during 2022-2030. Gene expression analysis examines how genes are recorded to synthesize functional gene products toward functional RNA species or protein products. The study of gene regulation helps provide visions into normal cellular processes, such as differentiation and abnormal or pathological processes. Researchers can perform gene expression analysis at one of the various levels at which the gene expression is regulated, namely transcriptional, post-transcriptional, translational, and post-translational protein modification.

End User-Based Insights

Based on end users, the PCR technologies market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, and others. The hospitals and diagnostic centers segment held a larger market share in 2022. Moreover, the same segment is anticipated to register a higher CAGR of 8.7% during 2022-2030. Hospitals and diagnostic centers contribute a significant market share to the PCR technologies market. Hospitals are the primary centers for patients seeking highly advanced treatment under the guidance of highly trained personnel. Various PCR technologies, such as dPCR and qPCR, offer high sensitivity and specificity, allowing early and accurate detection of pathogens, including bacteria, viruses, and fungi. Hospitals also offer advanced diagnosis and treatment options for patients to treat acute and chronic conditions, and the adoption of PCR techniques is much higher in hospitals and diagnostic centers as they provide healthcare facilities with specialized scientific equipment. Diagnostic laboratories are well-equipped with hi-tech equipment that enables easy workflow and management of various samples to be tested. For instance, Bio-Rad Laboratories, Inc., Fluidigm Corporation, Eppendorf, and Agilent Technologies, Inc. offer PCR devices to hospitals and diagnostic centers based on their capacity and requirements.

Food and Drug Administration, Pharmaceutical Research and Manufacturers Association, and Japan Bioindustry Association are some relevant sources referred to while preparing the PCR technologies market research report.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?